Body mass predicts the survival of patients with new international federation of gynecology and obstetrics stage IB1 and IB2 cervical carcinoma treated with radical hysterectomy

✍ Scribed by Michael A. Finan; Mitchel S. Hoffman; Richard Chambers; James V. Fiorica; Stephen DeCesare; Richard C. Kline; William S. Roberts; Denis Cavanagh

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 79 KB
• Volume: 83
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/(sici)1097-0142(19980701)83:1<98::aid-cncr13>3.0.co;2-7

✦ Synopsis

The authors evaluated the impact of body mass on survival and morbidity of patients with new International Federation of Gynecology and Obstetrics (FIGO) Stage IB1 and IB2 cervical carcinoma managed with radical hysterectomy.

METHODS.

Two hundred twenty-nine patients with Stage IB1 or IB2 cervical carcinoma treated with radical hysterectomy were studied in a multivariate logistic regression analysis. The body mass index (BMI) and the ponderal index (PI) were used as measures of body mass and were analyzed as predictors of recurrence, survival, and complications in light of the new staging system.